publication venue for First-Time-in-Human Study and Prediction of Early Bactericidal Activity for GSK3036656, a Potent Leucyl-tRNA Synthetase Inhibitor for Tuberculosis Treatment. 63. 2019 Discovery of novel oral protein synthesis inhibitors of mycobacterium tuberculosis that target leucyl-tRNA synthetase. 60:6271-6280. 2016 Linking murine and human Plasmodium falciparum challenge models in a translational path for antimalarial drug development. 60:3669-3675. 2016 Development of an intracellular screen for new compounds able to inhibit Mycobacterium tuberculosis growth in human macrophages. 60:640-645. 2015 Mycobacterium tuberculosis gyrase inhibitors as a new class of antitubercular drugs. 59. 2015 Histone methyltransferase inhibitors are orally bioavailable, fast-acting molecules with activity against different species causing malaria in humans. 59:950-959. 2015 Streptomycin-starved Mycobacterium tuberculosis 18b, a drug discovery tool for latent tuberculosis. 56. 2012 Aminoindoles, a Novel Scaffold with Potent Activity against Plasmodium falciparum. 55:2612-2622. 2011